Treatment options for hepatobiliary and pancreatic cancer

Steven R. Alberts, Gregory J. Gores, George P. Kim, Lewis R. Roberts, Michael L. Kendrick, Charles B. Rosen, Suresh T. Chari, James A. Martenson

Research output: Contribution to journalArticlepeer-review

49 Scopus citations


Hepatobiliary and pancreatic cancers account for 4% of all cancers in the United States. Traditionally, these cancers have had a high mortality rate and have been poorly responsive to therapy. Because of a growing number of treatment options, patients are now living longer. For hepatocellular carcinoma, a broad number of treatment options are available, including surgery, ablation, embolization, systemic therapy, and liver transplantation. Treatment options for cholangiocarcinoma include surgery, systemic therapy, and liver transplantation. For pancreatic cancer, surgery, radiation, and systemic therapy all have potential roles. This review provides an updated summary of diagnosis and assessment together with treatment options for this group of cancers.

Original languageEnglish (US)
Pages (from-to)628-637
Number of pages10
JournalMayo Clinic proceedings
Issue number5
StatePublished - May 2007

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Treatment options for hepatobiliary and pancreatic cancer'. Together they form a unique fingerprint.

Cite this